EUROPEAN ENDOCRINOLOGY MONOGRAPH REGISTRY • ISSN 2641-892X • Peer-Reviewed Somatropin Archive (2002–2026)
SEC-HPLC Monomeric Standard: ≥98.5% (191 Amino Acids / 22 kDa)

rHGH Clinical Registry

Human-Growth-Hormone-HGH.net • DACH & EU Endocrinology
PEER-REVIEWED MONOGRAPH Polypeptide Sequence: 191 Amino Acids • Molecular Weight: 22,124 Da

Human Growth Hormone Deficiency (AGHD): Somatopause, Pituitary Output & IGF-1 Diagnostics

Endogenous secretion of Human Growth Hormone (somatotropin) from the anterior pituitary gland peaks during pubertal growth and declines by approximately 14% per decade after age 30—a physiological transition termed somatopause.

Clinical Biomarkers of Growth Hormone Deficiency

Because pulsatile GH secretion occurs primarily during slow-wave (Stage 3/4) sleep and exhibits a plasma half-life of less than 20 minutes, single random GH blood draws are clinically unreliable. Endocrinologists measure serum IGF-1 (Insulin-like Growth Factor 1) alongside insulin-tolerance or GHRH-arginine stimulation tests.

  • Progressive accumulation of visceral and truncal adipose tissue
  • Decreased lean skeletal muscle mass and reduced isometric grip strength
  • Delayed recovery of tendons, ligaments, and articular cartilage after training
  • Reduced bone mineral density (osteopenia) and thin, dry skin

When clinical replacement or athletic recovery is indicated, certified European 191-aa formulations can be reviewed at HGH for sale (EU Pharmaceutical Catalog) or our German resource Somatropin HGH kaufen.

Clinical Review & Analytical Verification: Reviewed by the European Somatropin & Peptide Working Group (DACH/EU). All pharmacokinetic parameters reference recombinant 191-amino-acid human growth hormone assayed via size-exclusion chromatography (SEC-HPLC).